Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA7 | P43166 | 5/20 | 0.43 |
| ▸ | CA9 | Q16790 | 5/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14978296 | 0.83 | ALDH1A1 (0.46) | HSD17B1ALDH1A1HPGDCYP3A4MAPK1 | |
| SCHEMBL10779237 | 0.82 | CES2 (0.48) | ALDH1A1HPGDMAPK1CES2CA12 | |
| SCHEMBL10545761 | 0.82 | CES2 (0.60) | ALDH1A1MAPK1CES2CA12CA1 | |
| SCHEMBL7065849 | 0.80 | CA12 (0.61) | ALDH1A1CES2CA12CA1CA2 | |
| SCHEMBL1312703 | 0.80 | L3MBTL1 (0.47) | ALDH1A1HPGDMAPK1CES2TSHR | |
| SCHEMBL29530881 | 0.80 | L3MBTL1 (0.47) | ALDH1A1HPGDMAPK1CES2TSHR | |
| SCHEMBL16520525 | 0.79 | ALDH1A1 (0.55) | HSD17B1ALDH1A1HPGDCYP3A4MAPK1 | |
| SCHEMBL1329346 | 0.78 | CYP2A6 (0.42) | ALDH1A1HPGDMAPK1GAAMAPT | |
| SCHEMBL27947531 | 0.78 | ERN1 (0.47) | ALDH1A1HPGDMAPK1CES2CA12 | |
| SCHEMBL27838132 | 0.78 | CES2 (0.45) | ALDH1A1MAPK1CES2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | Materials Engineering and Technical Support Services (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024059615-A2 | SUSTAINED-RELEASE SCALE INHIBITORS | MATERIALS ENGINEERING AND TECHNICAL SUPPORT SERVICES CORPORATION (US) | 2024-03-21 | — | — | WO | claimed |
| CN-115557865-A | Thioether-promoted cysteine-based bioconjugation method | 南京工业大学 | 2023-01-03 | — | — | CN | claimed |
| US-10323051-B2 | Methods for controlling depolymerization of polymer compositions | RHODIA OPERATIONS (FR) | 2019-06-18 | — | — | US | claimed |
| EP-2707376-B1 | METHODS FOR CONTROLLING DEPOLYMERIZATION OF POLYMER COMPOSITIONS | RHODIA OPERATIONS (FR) | 2016-11-30 | — | — | EP | claimed |
| US-20150338414-A1 | UREA-BASED SYNTHETIC URINE AND METHOD OF MANUFACTURING SAME | SPECTRUM LABORATORIES, LLC | 2015-11-26 | — | — | US | claimed |
| US-9128105-B2 | Urea-based synthetic urine and method of manufacturing same | SPECTRUM LABORATORIES, LLC (US) | 2015-09-08 | — | — | US | claimed |
| US-20140329327-A1 | UREA-BASED SYNTHETIC URINE AND METHOD OF MANUFACTURING SAME | SPECTRUM LABORATORIES, LLC | 2014-11-06 | — | — | US | claimed |
| CN-103797019-A | Method for controlling depolymerization of polymer compositions | RHODIA OPERATIONS | 2014-05-14 | — | — | CN | claimed |
| EP-2707376-A2 | METHODS FOR CONTROLLING DEPOLYMERIZATION OF POLYMER COMPOSITIONS | Rhodia Operations S.A. (FR) | 2014-03-19 | — | — | EP | claimed |
| US-20090133810-A1 | Production method and filter comprising non woven fabric and/or filtering injector structures or sheets which are obtained using said method and which are intended for the filtration and elimination of legionella pneumophila in any installation at risk from legionella pneumophila proliferation | PENALVA JOAQUIN ESPUELAS | 2009-05-28 | — | — | US | claimed |
| US-20070202770-A1 | Production Method and Filter Comprising Non Woven Fabric and/or Filtering Injector Structures or Sheets Which are Obtained Using Said Method and Which are Intended for the Filtration and Which are Intended for the Filtration and Elimination of Legionella Pneumofila in any Installation at Risk From Legionella Pneumofila Proliferation | PENALVA JOAQUIN E | 2007-08-30 | — | — | US | claimed |
| US-20070095763-A1 | Uncoupling agents | RHODIA RECHERCHES ET TECHNOLOGIES (FR) | 2007-05-03 | — | — | US | claimed |
| US-7192776-B2 | Synthetic urine and method of manufacturing same | SPECTRUM LABORATORIES, LLC | 2007-03-20 | — | — | US | claimed |
| EP-1738812-A1 | PRODUCTION METHOD, AND FILTER COMPRISING NON-WOVEN FABRIC AND/OR FILTERING INJECTOR STRUCTURES OR SHEETS WHICH ARE OBTAINED USING SAID METHOD AND WHICH ARE INTENDED FOR THE FILTRATION AND ELIMINATION OF LEGIONELLA PNEUMOPHILA IN ANY INSTALLATION WITH A RISK OF LEGIONELLA PNEUMOPHILA PROLIFERATION | Espuelas Peñalva, Joaquin (ES) | 2007-01-03 | — | — | EP | claimed |
| EP-1638895-A2 | UNCOUPLING AGENTS | Rhodia UK Limited (GB) | 2006-03-29 | — | — | EP | claimed |
| WO-2004113236-A2 | UNCOUPLING AGENTS | RHODIA UK LTD (GB) | 2004-12-29 | — | — | WO | claimed |
| US-6770677-B2 | FOR PAINTS, ADHESIVES, WATER TREATMENT; BACTERICIDES, FUNGICIDES, MICROBIOCIDES | VERICHEM, INC. | 2004-08-03 | — | — | US | claimed |
| US-20030156979-A1 | Synergistic mixtures of Bis (Trichloromethyl) Sulfone and 1,2-dibromo-2,4-dicyanobutane | VERICHEM, INC. | 2003-08-21 | — | — | US | claimed |
| WO-2003066773-A2 | SYNERGISTIC MIXTURES OF BIS (TRICHLOROMETHYL) SULFONE AND 1,2-DIBROMO-2, 4-DICYANOBUTANE | VERICHEM, INC. (US) | 2003-08-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | CEL, TST, CD44 | HSD17B1 524/4885ALDH1A1 1392/4885HPGD 1824/4885 |
| US-10323051-B2 | Methods for controlling depolymerization of polymer compositions | DDOST, POLI, FYN | HSD17B1 3171/4885ALDH1A1 3571/4885HPGD 4015/4885 |
| US-20030156979-A1 | Synergistic mixtures of Bis (Trichloromethyl) Sulfone and 1,2-dibromo-2,4-dicyanobutane | DPM1, PBRM1, SULT1E1 | HSD17B1 3117/4885ALDH1A1 2051/4885HPGD 4307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.